Important Information Regarding BLENREP (belantamab mafodotin-blmf)


View Prescribing Information including Boxed Warning

For questions on options to support patients who are currently deriving clinical benefit, please contact GSK Response Center at: 1-877-768-0092

Trademarks are owned by or licensed to the GSK group of companies.

©2022 GSK or licensor.

BLMWCNT220031 November 2022

Produced in USA.